Strides Pharma Science Limited — Colchicine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Colchicine · $1.3M export value · DGFT Verified
Strides Pharma Science Limited is the #4 Indian exporter of Colchicine with $1.3M in export value and 30 verified shipments. Strides Pharma Science Limited holds a 6.2% market share in Colchicine exports across 6 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Colchicine Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Colchicine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $344.9K | 9 | 37.7% |
| UNITED KINGDOM | $173.7K | 9 | 19.0% |
| NETHERLANDS | $162.7K | 4 | 17.8% |
| DENMARK | $91.1K | 4 | 10.0% |
| GERMANY | $90.1K | 2 | 9.9% |
| CZECH REPUBLIC | $52.1K | 2 | 5.7% |
Strides Pharma Science Limited exports Colchicine to 6 countries. The largest destination is UNITED STATES accounting for 37.7% of Strides Pharma Science Limited's Colchicine shipments, followed by UNITED KINGDOM (19.0%) and NETHERLANDS (17.8%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Colchicine from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AVET PHARMACCEUTICALS INC., | UNITED STATES | $241.5K | 6 |
| STRIDES PHARMA UK LTD | UNITED KINGDOM | $110.3K | 6 |
| AVET PHARMACCEUTICALS INC | UNITED STATES | $103.4K | 3 |
| STRIDES NORDIC APS | DENMARK | $70.7K | 2 |
| BROCACEF HEALTHCARE LOGISTICS BV | NETHERLANDS | $50.0K | 1 |
| AUROBINDO PHARMA BVBAARNSCHE DIJK | NETHERLANDS | $50.0K | 1 |
| ZENTIVA, K.S. | CZECH REPUBLIC | $50.0K | 1 |
| FAIR-MED HEALTHCARE GMBH, | GERMANY | $50.0K | 1 |
| FAIR-MED HEALTHCARE GMBH | GERMANY | $40.1K | 1 |
| STRIDES PHARMA UK LTD, | UNITED KINGDOM | $35.0K | 2 |
Strides Pharma Science Limited supplies Colchicine to 15 buyers globally. The largest buyer is AVET PHARMACCEUTICALS INC., (UNITED STATES), followed by STRIDES PHARMA UK LTD (UNITED KINGDOM) and AVET PHARMACCEUTICALS INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Colchicine Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $12.0M worth of Colchicine through 1,739 shipments from 177 suppliers to 85 countries, serving 320 buyers globally. Strides Pharma Science Limited contributes $1.3M to this total, accounting for 6.2% of India's Colchicine exports. Strides Pharma Science Limited ships Colchicine to 6 countries through 15 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Colchicine Exports?
Strides Pharma Science Limited's average Colchicine shipment value is $43.8K per consignment, based on 30 shipments totaling $1.3M. The largest destination is UNITED STATES (37.7% of Strides Pharma Science Limited's Colchicine exports).
How Does Strides Pharma Science Limited Compare to Other Indian Colchicine Exporters?
Strides Pharma Science Limited ranks #4 among 177 Indian Colchicine exporters with a 6.2% market share. The top 3 exporters are ANNORA PHARMA PRIVATE LIMITED ($2.1M), ALKEM LABORATORIES LIMITED ($1.7M), BRAWN LABORATORIES LIMITED ($1.6M). Strides Pharma Science Limited processed 30 shipments to 6 destination countries.
What Colchicine Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Colchicine 500 micrograms Tablets 44,778 | $50.0K | 1 |
| COLCHICINE STRIDES 0.5MG TABLETTEN COLCH | $50.0K | 1 |
| COLCHICINE STRIDES 0.5MG TABLETTER COLCH | $50.0K | 1 |
| COLCHICINE TABLETS USP 0.6MGFC (33,0 | $50.0K | 1 |
| Colchicine Strides 05mg tabletten Colchicine 500 micrograms Tablets [EU] 101378.00 X 3X10'S | $50.0K | 1 |
| COLCHICIN ZENTIVAR 0.5MG TABLETTEN COLCHICINE 500 MICROGRAM TABLETS (EU) (52272X 3 X 10S) | $50.0K | 1 |
| COLCHICINE STRIDES 0,5 MG TABLETTER - COLCHICINE 500 MICROGRAMS TABLETS [EU] (9,771.00X 10X10'S) | $50.0K | 1 |
| COLCHICINE 500 MICROGRAMS TABLETS 32 105 00X 10X10 S | $48.4K | 2 |
| COLCHICINE TABLETS USP 0.6MGFC EACHFILM COATED TABLET CONTAINS COLCHICINE USP 0.6MG 13,360.000 PAC X 100S | $46.1K | 1 |
| COLCHICINE TABLETS USP 0.6MGFC EACHFILM COATED TABLET CONTAINS COLCHICINE USP 0.6MG 13,280.000 PAC X 100S | $45.7K | 1 |
Strides Pharma Science Limited exports 27 distinct Colchicine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Colchicine 500 micrograms Tablets 44,778 with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Colchicine to Key Markets
What Strides Pharma Science Limited must comply with to export Colchicine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Colchicine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED | $1.7M | 34 | 2 | $50.0K |
| 3 | BRAWN LABORATORIES LIMITED | $1.6M | 40 | 6 | $40.3K |
| 4 | STRIDES PHARMA SCIENCE LIMITED ★ | $1.3M | 30 | 6 | $43.8K |
| 5 | PAR FORMULATIONS PRIVATE LIMITED | $1.0M | 20 | 1 | $50.0K |
| 7 | MACLEODS PHARMACEUTICALS LTD | $753.3K | 45 | 10 | $16.7K |
Strides Pharma Science Limited ranks #4 among 177 Indian Colchicine exporters. Average shipment value of $43.8K compared to the market average of $67.5K. The closest competitors by value are ALKEM LABORATORIES LIMITED and BRAWN LABORATORIES LIMITED.
Which Indian Ports Ship Colchicine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 306 | 17.6% |
| DELHI AIR CARGO ACC (INDEL4) | 293 | 16.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 225 | 12.9% |
| DELHI AIR | 187 | 10.8% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 5.8% |
| Bombay Air | 69 | 4.0% |
| JNPT/ NHAVA SHEVA SEA | 58 | 3.3% |
| Delhi Air | 51 | 2.9% |
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Colchicine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Colchicine, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Colchicine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Colchicine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching Strides Pharma Science Limited exporting Colchicine, covering 27 formulations to 6 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 85+ countries, 320+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Colchicine Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Colchicine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Colchicine Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Colchicine. For current shipment-level data, contact TransData Nexus.